Phase II Study of Calcitriol-Enhanced Docetaxel in Patients With Previously Untreated Metastatic or Locally Advanced Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2015
At a glance
- Drugs Calcitriol; Docetaxel
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 01 Sep 2009 Additional lead trial centre Oregon Health and Science University identified as reported by ClinicalTrials.gov.
- 11 Aug 2009 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 11 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.